Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21 R-mediated JAK2/STAT3 pathway

被引:30
|
作者
Huang, Yanxia [1 ,2 ]
Zhang, Jing [2 ]
Wang, Ge [2 ]
Chen, Xiaoyu [2 ]
Zhang, Rui [2 ]
Liu, Hui [2 ]
Zhu, Jinshui [2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China
关键词
gastric cancer; growth; IL-21R; JAK2; oxymatrine; STAT3; INTERLEUKIN-21; RECEPTOR; IN-VITRO; GROWTH; CELLS; LYMPHOMA; PROLIFERATION;
D O I
10.1177/2058738418781634
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxymatrine (OMT) as a type of alkaloids collected from Sophora flavescens Ait exerts some biological functions including anticancer properties. Here, we investigated the therapeutic effects of OMT in gastric cancer cells (HGC 27 and AGS). As a result, the exposure of gastric cancer (GC) cells to OMT contributed to the suppression of cell proliferation and invasion. Interleukin 21 receptor (IL-21R) was identified to be differentially expressed between OMT treatment group (4mg/mL) and control group (0 mg/mL), and knockdown of IL-21 R repressed cell proliferation and invasion via inactivation of the JAK2/STAT3 pathway. The rescue experiment showed that IL-21R overexpression attenuated the anti-tumor effects of OMT through activation of the JAK2/STAT3 pathway. Moreover, the expression of IL-21R was significantly upregulated in GC samples compared with the adjacent normal tissues and associated with overall survival (OS) and tumor recurrence of GC patients. Taken together, in this study, we evaluated the anti-tumor effects of OMT on GC by investigating proliferation and invasion ability changes, and our findings show that OMT exhibits effects via regulation of JAK/STAT signaling pathway. Through the mechanism study, we may enlighten the potential therapeutic target for treatment of GC.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
    Wu, Liwei
    Li, Jingjing
    Liu, Tong
    Li, Sainan
    Feng, Jiao
    Yu, Qiang
    Zhang, Jie
    Chen, Jiaojiao
    Zhou, Yuting
    Ji, Jie
    Chen, Kan
    Mao, Yuqing
    Wang, Fan
    Dai, Weiqi
    Fan, Xiaoming
    Wu, Jianye
    Guo, Chuanyong
    CANCER MEDICINE, 2019, 8 (10): : 4806 - 4820
  • [22] IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer
    Wu, Xiaoqin
    Yang, Tao
    Liu, Xiang
    Guo, Jia Nian
    Xie, Tingting
    Ding, Yuanwei
    Lin, Manpeng
    Yang, Hui
    TUMOR BIOLOGY, 2016, 37 (04) : 5493 - 5501
  • [23] RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2/STAT3 pathway through autophagy suppression
    Wang, Zhongxiu
    Wei, Yingming
    Lei, Lihong
    Zhong, Jiahui
    Shen, Yeqi
    Tan, Jingyi
    Xia, Mengjiao
    Wu, Yanmin
    Sun, Weilian
    Chen, Lili
    CONNECTIVE TISSUE RESEARCH, 2021, 62 (04) : 411 - 426
  • [24] CCK2R induces the JAK2/STAT3 pathway activation in pancreatic cancer models
    Ferrand, A
    Kowalski-Chauvel, A
    Escrieut, C
    Bertrand, C
    Mathieu, A
    Pradayrol, L
    Fourmy, D
    Dufresne, M
    Seva, C
    REGULATORY PEPTIDES, 2004, 122 (01) : 17 - 17
  • [25] Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway
    Sun, Kuan-Xue
    Xia, Hong-Wei
    Xia, Rong-Long
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 615 - 621
  • [26] IL-37 mediates the anti-tumor activity in non-small cell lung cancer through IL-6/STAT3 pathway
    Deng, Yan-Ming
    Zhang, Hua
    Liang, Jian-Miao
    Xian, Hai-Bing
    Chen, Ze-Cheng
    Tang, Yi-Cong
    Yang, Shuang
    Feng, Wei-Neng
    JOURNAL OF APPLIED BIOMEDICINE, 2018, 16 (01) : 15 - 21
  • [27] Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
    Wei Wen
    Jun Wu
    Lucy Liu
    Yan Tian
    Ralf Buettner
    Meng-Yin Hsieh
    David Horne
    Thanh H Dellinger
    Ernest S Han
    Richard Jove
    John H Yim
    Molecular Cancer, 14
  • [28] Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway
    Guo, Haohao
    Wang, Ziyang
    Yin, Keyu
    Ma, Runsheng
    Zhang, Yifei
    Yin, Fanxiang
    Li, Hongqiang
    Yin, Detao
    MOLECULAR CARCINOGENESIS, 2024, 63 (04) : 701 - 713
  • [29] Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
    Wen, Wei
    Wu, Jun
    Liu, Lucy
    Tian, Yan
    Buettner, Ralf
    Hsieh, Meng-Yin
    Horne, David
    Dellinger, Thanh H.
    Han, Ernest S.
    Jove, Richard
    Yim, John H.
    MOLECULAR CANCER, 2015, 14
  • [30] The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis
    Yang Zhang
    Ji Li
    Haiying Zhong
    Xiang Xiao
    Zhihua Wang
    Zhao Cheng
    Cunhong Hu
    Guangsen Zhang
    Sufang Liu
    Cell Death Discovery, 7